Victory Capital Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.8M | Sell |
391,974
-1,862
| -0.5% | -$203K | 0.03% | 502 |
|
|
2026
Q1 | $36.4M | Buy |
393,836
+16,791
| +4% | +$1.69M | 0.02% | 660 |
|
|
2025
Q4 | $38.5M | Sell |
377,045
-96,988
| -20% | -$8.68M | 0.02% | 642 |
|
|
2025
Q3 | $29.6M | Sell |
474,033
-92,372
| -16% | -$5.02M | 0.02% | 752 |
|
|
2025
Q2 | $29.5M | Buy |
566,405
+346,281
| +157% | +$15.5M | 0.02% | 739 |
|
|
2025
Q1 | $9.38M | Buy |
220,124
+205,546
| +1,410% | +$8.87M | 0.01% | 1077 |
|
|
2024
Q4 | $445K | Sell |
14,578
-260
| -2% | -$7.31K | ﹤0.01% | 2052 |
|
|
2024
Q3 | $340K | Sell |
14,838
-147
| -1% | -$4.16K | ﹤0.01% | 2109 |
|
|
2024
Q2 | $433K | Sell |
14,985
-274
| -2% | -$6.38K | ﹤0.01% | 2016 |
|
|
2024
Q1 | $315K | Buy |
15,259
+211
| +1% | +$4.52K | ﹤0.01% | 2107 |
|
|
2023
Q4 | $407K | Buy |
15,048
+2,632
| +21% | +$69K | ﹤0.01% | 2051 |
|
|
2023
Q3 | $368K | Buy |
12,416
+299
| +2% | +$10.5K | ﹤0.01% | 2070 |
|
|
2023
Q2 | $434K | Buy |
12,117
+1,213
| +11% | +$34.8K | ﹤0.01% | 2025 |
|
|
2023
Q1 | $256K | Sell |
10,904
-1
| -0% | -$29 | ﹤0.01% | 2190 |
|
|
2022
Q4 | $297K | Sell |
10,905
-5
| -0% | -$229 | ﹤0.01% | 2175 |
|
|
2022
Q3 | $587K | Sell |
10,910
-1,261
| -10% | -$64.7K | ﹤0.01% | 1971 |
|
|
2022
Q2 | $491K | Sell |
12,171
-64
| -0.5% | -$3.17K | ﹤0.01% | 2060 |
|
|
2022
Q1 | $755K | Sell |
12,235
-928
| -7% | -$63.5K | ﹤0.01% | 1947 |
|
|
2021
Q4 | $1.32M | Sell |
13,163
-15,138
| -53% | -$1.57M | ﹤0.01% | 1709 |
|
|
2021
Q3 | $3.54M | Sell |
28,301
-25,995
| -48% | -$3.09M | ﹤0.01% | 1423 |
|
|
2021
Q2 | $6.74M | Sell |
54,296
-17,031
| -24% | -$2.29M | 0.01% | 1245 |
|
|
2021
Q1 | $10.9M | Buy |
71,327
+40,446
| +131% | +$6.11M | 0.01% | 1120 |
|
|
2020
Q4 | $3.98M | Buy |
30,881
+892
| +3% | +$103K | ﹤0.01% | 1303 |
|
|
2020
Q3 | $3.35M | Sell |
29,989
-5,442
| -15% | -$498K | ﹤0.01% | 1289 |
|
|
2020
Q2 | $2.88M | Sell |
35,431
-293
| -0.8% | -$23.6K | ﹤0.01% | 1319 |
|
|
2020
Q1 | $2.49M | Buy |
35,724
+7,618
| +27% | +$585K | ﹤0.01% | 1262 |
|
|
2019
Q4 | $2.2M | Buy |
28,106
+2,792
| +11% | +$201K | ﹤0.01% | 1480 |
|
|
2019
Q3 | $1.62M | Buy |
25,314
+24,709
| +4,084% | +$2.18M | ﹤0.01% | 1538 |
|
|
2019
Q2 | $52K | Sell |
605
-231
| -28% | -$17.6K | ﹤0.01% | 1726 |
|
|
2019
Q1 | $64K | Sell |
836
-2,475
| -75% | -$137K | ﹤0.01% | 1690 |
|
|
2018
Q4 | $124K | Buy |
+3,311
| New | +$122K | ﹤0.01% | 1617 |
|
Other funds holding GH
DTC
Victory Capital Management's GH Position: Q2 2026 in Review
Victory Capital Management reduced its Guardant Health (GH) stake by 0.47% in Q2 2026, selling an estimated $203K and leaving 391,974 shares worth $58.8M. The position accounts for 0.03% of the portfolio, ranked #502.
Victory Capital Management first reported a position in GH in Q4 2018 and has held it in 31 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Victory Capital Management held 391,974 shares of Guardant Health worth $58.8M as of Q2 2026.
- Victory Capital Management sold 1,862 Guardant Health shares in Q2 2026, an estimated $203K.
- Guardant Health made up 0.03% of Victory Capital Management's portfolio in Q2 2026, its #502 holding.
- Victory Capital Management first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.